Home › Funds › Manulife Financial › FDMT
Manulife Financial position in FDMT
4D MOLECULAR THERAPEUTICS IN · Health Care
Latest position (Q2 2026)12.49K sh
Reported value held$166.10K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 11.18K | $301.00K | New |
| Q4 2021 | 13.83K | $304.00K | Add |
| Q1 2022 | 11.78K | $178.00K | Reduce |
| Q2 2022 | 13.07K | $91.00K | Add |
| Q3 2022 | 12.62K | $101.00K | Reduce |
| Q4 2022 | 12.02K | $267.05K | Reduce |
| Q1 2023 | 12.02K | $206.69K | Hold |
| Q2 2023 | 12.71K | $229.72K | Add |
| Q3 2023 | 14.95K | $190.25K | Add |
| Q4 2023 | 14.95K | $302.79K | Hold |
| Q1 2024 | 15.12K | $481.88K | Add |
| Q2 2024 | 18.98K | $398.29K | Add |
| Q3 2024 | 18.42K | $199.13K | Reduce |
| Q4 2024 | 18.48K | $102.92K | Hold |
| Q1 2025 | 18.59K | $60.05K | Add |
| Q2 2025 | 14.85K | $55.09K | Reduce |
| Q3 2025 | 14.28K | $124.11K | Reduce |
| Q4 2025 | 12.60K | $94.46K | Reduce |
| Q1 2026 | 12.26K | $114.10K | Reduce |
| Q2 2026 | 12.49K | $166.10K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding FDMT
- BlackRock Inc 4.55M sh · $60.46M · Q2 2026
- Goldman Sachs Group 4.26M sh · $56.64M · Q2 2026
- Janus Henderson Group 5.25M sh · $48.87M · Q1 2026
- Vanguard Group 3.09M sh · $23.20M · Q4 2025
- Geode Capital Management 1.13M sh · $15.01M · Q2 2026
- Bank of America Corp 1.12M sh · $14.90M · Q2 2026
- Deutsche Bank AG 710.94K sh · $9.46M · Q2 2026
- Renaissance Technologies 614.57K sh · $8.17M · Q2 2026
- Northern Trust Corp 562.93K sh · $7.49M · Q2 2026
- Morgan Stanley 503.02K sh · $6.69M · Q2 2026
- JPMorgan Chase & Co 402.14K sh · $5.18M · Q2 2026
- Charles Schwab Investment Management 339.27K sh · $4.51M · Q2 2026